WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 292
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 352

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 11  11  11  11  10  10 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported cases

(Click for retrospective incidence data for Nauru)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  11  300  10 
Mumps
ChartChart
 
Pertussis
ChartChart
  166 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nauru)
Vaccine year result method % card seen                                                
BCG 2006  98  DHS   95  99*  98  99*  93 
DTP1 2006  98  DHS   95  98  80  98  85 
DTP3 2006  89  DHS   95  91  75  79  44 
DTP4          47  33 
IPV1          91  99* 
HepB_BD          99*  98  99*  98 
HepB3          91  95  79  58 
Hib3          91  75  79 
JapEnc         
MCV1          98  65  96 
MCV2          96  49  81 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2006  91  DHS   95  91  75  79  27 
Rota1         
RotaC         
RCV1          98  65  96 
TT2plus          24 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nauru)
BCG
ChartChart
  99  99  99  99  99  93  93 
DTP1
ChartChart
  98  98  99  99  98  85  90 
DTP3
ChartChart
  91  91  95  87  79  44  74 
HepB3
ChartChart
  91  91  95  87  79  58 
HepB_BD
ChartChart
  99  99  99  99  99  98 
Hib3
ChartChart
  91  91  95  87  79 
IPV1
  91  91 
MCV1
ChartChart
  98  98  98  97  96 
MCV2
ChartChart
  96  96  94  88  81 
PCV3
 
Pol3
ChartChart
  91  91  95  87  79  27  74 
RCV1
ChartChart
  98  98  98  97  96 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes
IPV 14 weeks; Yes
MR 12, 15 months; Yes
OPV 6, 10, 14 week; 18 months; 4 years; Yes
TT 1st contact; +4 weeks; +6 months; No

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR   No  No    No  No  Yes 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number             14 

System performance

Total Nº districts in country number     14    14 
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%         100     
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%            

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND   No  No    No  No  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR   No  No    No  No  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%   100        NA   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR   No  No    No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.